OBJECTIVES: Survival of patients with left-sided stage I non-small cell lung cancer (NSCLC) is unsatisfactory, probably because of the high incidence of contralateral mediastinal node involvement. In this study, occult micrometastases to the right upper mediastinal nodes were retrospectively investigated in patients with left-sided stage I NSCLC.
INTRODUCTION
The prognosis of patients with surgical resection for stage I nonsmall cell lung cancer (NSCLC) is unsatisfactory. In particular, the survival of patients with left lower lobe cancer is less than that of patients with right upper lobe cancer [1] , probably due to the high incidence of right paratracheal node involvement in left lung cancer [2, 3] and residual occult micrometastases. The incidence of micrometastases to the regional lymph nodes in patients with stage I lung cancer has been reported to range from 16 to 64% [4] [5] [6] [7] [8] . Among those reports, Kawano et al. reported that micrometastases were detected in 26.5% of patients with stage I left lung cancer [6] using immunohistochemical (IHC) staining methods [7] .
In this study, to investigate the incidence of occult micrometastases to the right upper mediastinal nodes from left lung cancer, video-assisted thoracoscopic (VATS) lobectomy with bilateral mediastinal node dissection (BMD) was performed in patients with clinical stage I NSCLC using a real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR) method. Furthermore, whether BMD improves survival for patients with resected stage I non-small cell left lung cancer was also examined.
MATERIALS AND METHODS
From January 2004 to September 2011, 147 patients underwent VATS left lung resection for primary clinical stage I NSCLC. Of these, the data of 19 patients who underwent VATS lobectomy and BMD were retrospectively analysed and compared with the historical data of patients who underwent left unilateral mediastinal node dissection (UMD).
The patients were selected based on the following criteria: age <80 years, no serious concomitant diseases, and no diffuse pleural adhesions of the right lung. Pure ground grass attenuation lesions on chest computer tomography scan were excluded. Patients were classified into two groups: 19 patients with BMD between January 2008 and September 2011, and 25 (historical controls) with UMD between January 2004 and December 2007.
Postoperative parameters including operative time, blood loss, number of dissected lymph nodes, postoperative complications, duration of chest tube drainage and duration of postoperative hospital stay were compared between the two patient groups. Lymph node metastasis was evaluated histologically by haematoxylineosin staining. Nodal micrometastases were detected using a realtime RT-PCR of cytokeratin 19 (CK19) mRNA expression.
This study, conducted according to the institutional and ethical rules concerning research on tissue specimens, was exempted from the requirement for informed consent from the patients.
Operative procedure
Initially, right upper mediastinal dissection was performed. When the diagnosis of the left lung tumour was not established, VATS lung biopsy was performed on patients in the right decubitus position prior to right mediastinal dissection. When cancer was diagnosed on pathological examination of frozen tumour specimens, right paratracheal node and subcarinal node dissection was performed on patients in the left decubitus position. Then, the patients underwent VATS lung lobectomy and left mediastinal dissection in the right decubitus position.
Right paratracheal node dissection by video-assisted thoracoscopic
Patients were put in the left decubitus position, and five ports were inserted through the right inter-costal space. The scope port was inserted through the seventh inter-costal space at the midaxillary line, the surgeon's access ports were inserted through the auscultation triangle and the seventh inter-costal space at the posterior axillary line and the assistant's ports were inserted through the fourth and sixth inter-costal spaces at the anterior axillary line. The upper mediastinal pleura were opened along the right vagus nerve.
The superior mediastinum encompassed by the trachea, superior vena cava (SVC) and azygos vein was exposed by retracting the lung inferiorly. The phrenic and vagus nerves were identified. The mediastinal pleura were incised along the vagus nerve to the level of the subclavian artery. The azygos vein and the vagus nerve were taped and elevated. The mediastinal fat pad containing #2R, #4R and #10R lymph nodes was removed from the cephalad border of the trunks of the right upper pulmonary artery to the subclavian artery, and from the SVC to the trachea. The recurrent laryngeal nerve was identified at the level of the subclavian artery, and then dissection of posterior mediastinal nodes (#3p) between the oesophagus and the trachea was performed. When the #3a nodes were found, the anterior mediastinum was dissected. Lymph node classification was according to the seventh edition of the American Joint Committee on Cancer Staging Manual [9] .
Subcarinal node dissection
The subcarinal region was exposed by retracting the lung anteriorly. The oesophagus was retracted posteriorly and the intermediate bronchus, anteriorly. The subcarinal nodes (#7) and hilar (#10) nodes were grasped with Russian forceps, elevated from the pericardium and removed.
Left mediastinal node dissection
Patients were put in the right decubitus position, and five ports were inserted through the left inter-costal space mirroring the right port sites. The mediastinal pleura were incised along the phrenic and vagus nerves. The nerves were taped and elevated. The lymph node-containing fat pad anterior to the ligamentum arteriosum (#6) and posterior to the ligamentum (#5) was removed. The lung was retracted inferiorly, and the main pulmonary artery was compressed with a large cotton stick, and then lymph nodes (#4L) were removed from the left main stem bronchus, recurrent laryngeal nerve and trachea. Laparoscopic coagulating shears were usually used for dissection. Dissection of nearby nerves was performed by bipolar scissors.
Branches of the left pulmonary artery and the pulmonary vein were dissected, the lobar bronchus was cut using a stapler, and then a lobe was removed via the fourth inter-costal port site, where the skin incision was extended to 3 cm.
Extraction of RNA and reverse transcriptionpolymerase chain reaction
Lymph node tissues were frozen immediately with RNA and laterTM (QIAGEN, Hilden, Germany), and stored at −80°C until RNA extraction. RNA was extracted using an RNeasy Mini Kit (QIAGEN) from lymph node tissues. Quantification of the CK19 gene was performed on a Smart Cycler II (Cepheid) using the TaKaRa One Step SYBR RT-PCR Kit (TaKaRa, RR066A).
Forward primer (F) and reverse primer (R) sequences were as follows: CK19-F, gccactactacacgaccatcc; CK19-R, caaacttggttcggaagtcat (126 bp). The PCR condition was set at 40 cycles of 95°C for 5 s and 60°C for 2 s.
Step 3 (Melt Curve). The measured value was calculated by comparative Ct methods, and GAPDH gene amplification was used as a control. All reactions were duplicated. CK-19 mRNA was expressed as n-fold GAPDH mRNA, and the levels were compared relative to normal lymph node samples.
Statistical analysis
The statistical analyses were performed using JMP version 4.0.5j software (SAS institute, Cary, NC, USA) Differences in proportions were compared using the χ 2 test and continuous data were compared by the Mann-Whitney U-test. Survival curves were estimated by the Kaplan-Meier method, and differences were analysed by the log-rank test; a difference of P < 0.05 was considered THORACIC statistically significant. Also, we analysed the hazard ratio (HR) by the univariate Cox-regression model.
RESULTS
There were no significant differences in the characteristics of the patients between the BMD and UMD groups, including age, sex, histological types of tumours and pathological stage ( Table 1) .
The operative time for left hemi-thorax, blood loss, number of dissected lymph nodes in the subcarina and left upper mediastinum, duration of chest tube drainage and duration of postoperative hospital stay were not significantly different between the two groups ( Table 2) .
No patients died within 30 days postoperatively. There were no serious complications, and the morbidity rate was not different between the two groups (Table 3) .
Pathologically, upstaging to pN2 stage IIIA disease was observed in only 1 of 19 patients (5.3%), and pN0 disease was seen in 18 of 19 patients (94.7%). The number of dissected lymph nodes was 736 in 160 stations (4.6/station). The number of stations with micrometastases was 13/160 (8.1%). Nodal micrometastases were detected in 11/19 (57.8%) patients with clinical N0 stage I disease. Micrometastases to the level N1, N2 and N3 nodes were detected in 1 (5.6%), 2 (11.1%) and 8 (42.1%) of 18 patients with pN0 disease, respectively (Table 4) .
Of these, the tumour pathological type was adenocarcinoma in 9/11 (81.8%) patients and squamous cell carcinoma in 2/11 (18.2%) ( Table 5 ). Skip micrometastases to the level N3 nodes without N1 and N2 node involvement were observed in 7/11 (63.6%) patients (Table 5) . Figures 1 and 2 show overall survivals and disease-free survivals, respectively. The median follow-up periods of BMD patients and UMD patients were 21.4 and 43.9 months, respectively. All BMD patients are alive and have had no recurrence. The overall 3-year survival rate and the disease-free survival rate of BMD patients were both 100%, while those of UMD patients were 86.1 and 72.9%, respectively. Five of 25 UMD patients died due to cancer recurrence during follow-up periods. There was no significant difference in the 3-year overall and disease-free survival rate between BMD and UMD patients. When we analysed the HR by the univariate Cox-regression model, HR in overall 
DISCUSSION
Generally, bilateral mediastinal node dissection is performed using a median sternotomy [3] . Additionally, video-assisted mediastinoscopy [10] , transcervical extended lymphadenectomy [11, 12] and blunt dissection through the aorto-pulmonary window via left thoracotomy have been reported [13] . In the present patients, VATS-BMD was used, because median sternotomy is a more invasive approach than VATS for elderly patients, and we have no experience of mediastinoscopy, transcervical dissection and blunt dissection through the aorto-pulmonary window. We have previously reported the safety of VATS-BMD [14] . The incidence of metastases to the right paratracheal nodes from left lung cancer has been reported to be 21.3-44% in total left lung cancer, 18.2-40% in left upper lobe tumours and 28.6-33% in left lower lobe tumours [2, 3] . Hata et al. [3] demonstrated the lymphatic drainage from the segmental bronchi of the left lung using lymphoscintigraphy. There are two routes to the right scalene nodes: (1) through the right or left paratracheal nodes from the left tracheobronchial nodes and (2) through the right pre-and paratracheal nodes from the sub-carinal nodes. The lobe-specific extent of cancer is well known; the most common metastatic station of left upper lung cancer was the subaortic and para-aortic nodes (#5, #6) with an incidence of 71.4-74%, and the next most common metastatic site was the left tracheobronchial nodes, with an incidence of 42.8-58% [15, 16] .
Traditionally, IHC methods are used to detect micrometastases using antibodies directed against epithelial or genetic elements found within tissues harbouring tumours. IHC detects more than twice as many positive regional lymph nodes as does H&E staining [17] . In the present study, real-time RT-PCR was used to detect micrometastases [18] [19] [20] , because micrometastases can be identified with the RT-PCR method when they are missed by the IHC method [21] .
Recurrence in early-stage lung cancers is likely due to the presence of residual micrometastases [5, 21] . Gu et al. [5] showed that 45% of their patients with micrometastases developed recurrence, compared with 7% of patients without micrometastases. Nosotti et al. [18] demonstrated that micrometastases that were detected by carcinoembryonic antigen mRNA were the most powerful predictors of cancer recurrence. Benlloch et al. [22] reported that disease-free survival and overall survival were significantly worse in patients with than without carcinoembryonic antigen-related cell adhesion molecule and/or palate, lung and nasal epithelium clone protein expression. Micrometastases that were detected by IHC were independently associated with 1  S3  12  Sq  T1aN0, IA  T1aN0, IA  N3, IIIB  #4R  2  S3  43  Ad  T2aN0, IB  T2aN0, IB  N1, IIA  #11  3  S6  20  Ad  T1bN0, IA  T1aN0, IA  N3, IIIB  #2R  4  S6  26  Sq  T1bN0, IA  T1bN0, IA  N3, IIIB  #2R, #4L  5  S3  25  Ad  T1bN0, IA  T1bN0, IA  N2, IIIA  #4L  6  S6  13  Ad  T1aN0, IA  T2aN0, IB  N3, IIIB  #4R  7  S1 + 2  28  Ad  T1bN0, IA  T2aN2, IIIA  #5  N3, IIIB  #10R  8  S6  52  Ad  T2aN0, IB  T2bN0, IIA  N3, IIIB  #3p  9  S6  22  Ad  T2aN0, IB  T1bN0, IA  N1, IIA  #10  10 There is no significant difference between BMD and UMD patients.
THORACIC
an increased risk of poor survival in patients who underwent a surgical resection of stage I non-small cell left lung cancer [23] . Pathologically, the incidence of skip-N2 metastases without N1 nodal involvement occurred in 18-29% of patients with pN2 disease [23] [24] [25] . The incidence of skip micrometastases has ranged from 28 to 100% [6, 17, 19] . Ilic and colleagues reported that postoperative survival of patients with skip-N2 disease was almost the same as that of patients with pN2 disease with N1 node involvement [24] . On the other hand, the survival of patients with skip-N2 metastases was better than that of patients with N1 node involvement [21, 25] . According to micrometastases, patients with pN0 and pN1 disease with micrometastases had no difference in cancer-related survival compared with patients with pN2 disease [21] .
Our BMD patients with skip N3 micrometastases are all alive and have had no recurrence during a median follow-up period of 21 months after surgery. However, a limitation of this study is that it is a single institutional study; furthermore, at this time, the number of patients is too small and the duration of follow-up is too short to determine whether the prognosis of patients with level N3 node micrometastases is worse and whether the dissection of level N3 nodes with skip micrometastases contributes to improved survival.
CONCLUSION
In this preliminary study, occult micrometastases to the contralateral mediastinal nodes occurred frequently in patients who underwent VATS lobectomy with bilateral mediastinal lymph node dissection for clinical N0 stage I non-small-cell left lung cancer. Further follow-up and work are needed to define whether the presence of occult micrometastases to the level N3 nodes in left lung cancer is a predictor of cancer recurrence and worse survival after surgery for patients with stage I non-small cell left lung cancer.
